Initial Announcement Back to the Grants Dashboard
STATE OPIOID RESPONSE (SOR) FUNDING OPPORTUNITY ANNOUNCEMENT (FOA) APPLICANT CONFERENCE CALL:
SAMHSA is holding a conference call for SOR applicants on Tuesday, August 7, 2018 from 3:00 pm – 4:00 pm ET.
Call-In Number: 888-469-0490
Participant passcode: 2951675
Notice of Funding Opportunity (NOFO)
NOFO Number: TI-18-015
Posted on Grants.gov: Thursday, June 14, 2018
Application Due Date: Monday, August 13, 2018
Catalog of Federal Domestic Assistance (CFDA) Number: 93.788
Intergovernmental Review (E.O. 12372):
Public Health System Impact Statement (PHSIS) / Single State Agency Coordination:
The Substance Abuse and Mental Health Services Administration (SAMHSA) is accepting applications for fiscal year (FY) 2018 State Opioid Response Grants (Short Title: SOR). The program aims to address the opioid crisis by increasing access to medication-assisted treatment using the three FDA-approved medications for the treatment of opioid use disorder, reducing unmet treatment need, and reducing opioid overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder (OUD) (including prescription opioids, heroin and illicit fentanyl and fentanyl analogs). These grants will be awarded to states and territories via formula. The program also includes a 15 percent set-aside for the ten states with the highest mortality rate related to drug overdose deaths.
Grantees will be required to do the following: use epidemiological data to demonstrate the critical gaps in availability of treatment for OUDs in geographic, demographic, and service level terms; utilize evidence-based implementation strategies to identify which system design models will most rapidly and adequately address the gaps in their systems of care; deliver evidence-based treatment interventions that include medication(s) FDA-approved specifically for the treatment of OUD, and psychosocial interventions; report progress toward increasing availability of medication-assisted treatment for OUD; and reducing opioid-related overdose deaths.
The program supplements activities pertaining to opioids currently undertaken by the state agency and will support a comprehensive response to the opioid epidemic. The results of the assessments will identify gaps and resources from which to build upon existing substance use prevention and treatment activities as well as community-based recovery support services. Grantees will be required to describe how they will expand access to treatment and recovery support services. Grantees will also be required to describe how they will advance substance misuse prevention in coordination with other federal efforts. Grantees must use funding to supplement and not supplant existing opioid prevention, treatment, and recovery activities in their state. Grantees are required to describe how they will improve retention in care, using a chronic care model or other innovative model that has been shown to improve retention in care.
Eligible applicants are the Single State Agencies (SSAs) and territories. Please note that Tribes will be eligible to apply for opioid response funding under a separate announcement.
[See Section III-1 for complete eligibility information.]
Funding Mechanism: Grant
Anticipated Total Available Funding: $930,000,000 (This includes a 15 percent set-aside for the ten states hardest hit by the crisis).
Anticipated Number of Awards: 59 awards
Anticipated Award Amount: See Appendix K for distribution
Length of Project: Up to 2 years
Cost Sharing/Match Required?: No
State allocations for the Opioid SOR grants are calculated by a formula based on the equal weighting of two elements: the state’s proportion of people with abuse or dependence on opioids (prescription opioids and/or heroin) who need but do not receive treatment (NSDUH, 2015-2016) and the state’s proportion of drug poisoning (overdose) deaths (CDC National Vital Statistics System, 2016). Each State, as well as the District of Columbia, will receive not less than $4,000,000. Each territory will receive not less than $250,000. See Appendix K for more information. In addition to this base distribution, $142.5 million in funding is being distributed to the ten states with the highest mortality rates due to drug poisoning deaths. This set-aside takes into account the state’s ordinal ranking in the top ten; it is not distributed equally among the ten states.
Annual continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.
For questions on this announcement contact:
Grants Management and Budget Issues
For questions on this announcement contact: